ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,895Medicare Part D Prescriptions Filled, Including Refills

Rank: 552 out of 3001

$499K Total Retail Price of All Prescriptions

Rank: 641 out of 3001

509 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 509 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 509 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 7,678 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 390 363 1 3
FUROSEMIDE 335 300 2 6
LISINOPRIL 304 245 3 2
METOPROLOL TARTRATE 283 245 4 8
SIMVASTATIN 226 182 5 1
WARFARIN SODIUM 209 202 6 12
OMEPRAZOLE 202 188 7 4
NAMENDA 200 200 8 40
DONEPEZIL HCL 190 190 9 27
HYDROCODONE-ACETAMINOPHEN 180 132 S3 10 7
POTASSIUM CHLORIDE 167 155 11 15
GABAPENTIN 153 108 12 14
AMLODIPINE BESYLATE 152 146 13 5
CITALOPRAM HBR 151 130 14 16
TRAZODONE HCL 141 113 15 37
TRAMADOL HCL 133 124 16 17
MIRTAZAPINE 117 109 17 44
SERTRALINE HCL 114 109 18 20
METOPROLOL SUCCINATE 104 103 19 19
NOVOLOG 93 84 20 94
FAMOTIDINE 93 84 20 68
CARVEDILOL 90 82 22 25
PLAVIX 80 63 23 46
PANTOPRAZOLE SODIUM 79 75 24 43
TAMSULOSIN HCL 78 78 25 29
ALENDRONATE SODIUM 78 74 25 26
LOSARTAN POTASSIUM 76 65 27 21
METFORMIN HCL 73 41 28 9
ATORVASTATIN CALCIUM 72 62 29 11
ALLOPURINOL 69 63 30 35
LANTUS 69 59 30 47
POLYETHYLENE GLYCOL 3350 66 44 32 55
MELOXICAM 63 62 33 34
OXYCODONE-ACETAMINOPHEN 63 36 S2 33 32
FLUOXETINE HCL 62 56 35 61
CARBIDOPA-LEVODOPA 60 60 36 97
GENERLAC 59 52 37 173
ADVAIR DISKUS 59 48 37 58
PRAVASTATIN SODIUM 59 46 37 13
ISOSORBIDE MONONITRATE ER 56 55 40 45
DIOVAN 52 52 41 50
ZOLPIDEM TARTRATE 52 40 41 24
LEVOFLOXACIN 51 44 43 115
PREDNISONE 50 44 44 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.